CLINICAL ROLE -
Ado-trastuzumab Emtansine (Kadcyla)
This human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugate is approved for the treatment of patients with HER2-positive, metastatic breast cancer.
Read More